Zura Bio officer reports share and option holdings
Zura Bio Ltd reports that officer Mathew Marlyn Teresa, VP and Principal Accounting Officer, holds 129,182 Class A ordinary shares, including 32,296 shares underlying restricted stock units that vest in full on May 18, 2027 if continuous service is maintained.
Rhea-AI Filing Summary
Zura Bio Ltd reports that officer Mathew Marlyn Teresa, VP and Principal Accounting Officer, holds 129,182 Class A ordinary shares, including 32,296 shares underlying restricted stock units that vest in full on May 18, 2027 if continuous service is maintained.
He also holds several employee share options over Class A ordinary shares, including 66,220 shares at an exercise price of $6.03, 81,150 shares at $1.20, 90,000 shares at $3.38, and additional tranches at a $0.00 exercise price, with expirations between 2032 and 2036. The option awards vest over time, with initial vesting dates on March 15, 2024, June 18, 2025, February 27, 2026 and April 1, 2027, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Mathew Marlyn Teresa
Role
VP, Principal Acctg. Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Share Option (Right to Buy) | -- | -- | -- |
| holding | Employee Share Option (Right to Buy) | -- | -- | -- |
| holding | Employee Share Option (Right to Buy) | -- | -- | -- |
| holding | Employee Share Option (Right to Buy) | -- | -- | -- |
| holding | Employee Share Option (Right to Buy) | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Employee Share Option (Right to Buy) — 286,008 contracts (Direct);
Class A Ordinary Shares — 129,182 shares (Direct)
Footnotes (8)
- F1. Includes 32,296 shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in full on May 18, 2027, subject to the Reporting Person's continuous service through such vesting date.
- F2. Immediately exercisable.
- F3. $0.83732
- F4. One fourth (1/4) of the shares subject to the option award vested on March 15, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) monthly installments thereafter on the last day of the month, subject to the Reporting Person's continuous service through such vesting date.
- F5. $1.19593
- F6. One fourth (1/4) of the shares subject to the option award vested on June 18, 2025 and the remaining shares subject to the option vested or shall vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
- F7. One fourth (1/4) of the shares subject to the option award vested on February 27, 2026 and the remaining shares subject to the option vested or shall vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
- F8. One fourth (1/4) of the shares subject to the option award shall vest on April 1, 2027 and the remaining shares subject to the option shall vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Direct share holdings: 129,182 Class A ordinary shares
RSU underlying shares: 32,296 shares
Option block at $6.03: 66,220 underlying shares at $6.03
+4 more
7 metrics
Direct share holdings
129,182 Class A ordinary shares
Shares held following reported holdings
RSU underlying shares
32,296 shares
Restricted stock units vesting on May 18, 2027
Option block at $6.03
66,220 underlying shares at $6.03
Employee share option expiring April 1, 2036
Option block at $1.20
81,150 underlying shares at $1.20
Employee share option expiring February 27, 2035
Option block at $3.38
90,000 underlying shares at $3.38
Employee share option expiring June 18, 2034
Zero-cost option block 1
11,133 underlying shares at $0.00
Employee share option expiring March 15, 2033
Zero-cost option block 2
37,505 underlying shares at $0.00
Employee share option expiring June 8, 2032
Key Terms
restricted stock units ("RSUs"), Employee Share Option (Right to Buy), exercise price, vest in full, +1 more
5 terms
restricted stock units ("RSUs") financial
"Includes 32,296 shares underlying restricted stock units ("RSUs"). Each RSU represents"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
exercise price financial
"exercisePrice": "6.0300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in full financial
"The RSUs shall vest in full on May 18, 2027"
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date"
FAQ
How many restricted stock units does Zura Bio's VP hold according to the Form 3?
The filing shows 32,296 shares underlying restricted stock units for Mathew Marlyn Teresa. Each RSU equals one Class A ordinary share and is scheduled to vest in full on May 18, 2027, assuming he remains in continuous service.
What stock options does Zura Bio (ZURA) report for Mathew Marlyn Teresa?
Zura Bio lists several employee share options for Mathew Marlyn Teresa, including 66,220 shares at $6.03, 81,150 at $1.20, and 90,000 at $3.38. Additional zero-cost options cover 11,133 and 37,505 shares, with expirations between 2032 and 2036.
When do Zura Bio executive stock options for Mathew Marlyn Teresa vest?
The options vest over time, with one-fourth tranches vesting on March 15, 2024, June 18, 2025, February 27, 2026 and April 1, 2027. Remaining shares vest in monthly or quarterly installments, subject to his continuous service through each vesting date.
What is the nature of Zura Bio (ZURA) VP's holdings in this insider filing?
The insider filing shows direct ownership in both Class A ordinary shares and multiple employee share options. No buy or sell transactions are reported; the disclosure focuses on existing holdings, vesting schedules and option exercise prices for the executive.
AI-generated analysis. How Rhea-AI works. Not financial advice.
